Literature DB >> 1585925

End-stage renal disease in US minority groups.

H I Feldman1, M J Klag, A P Chiapella, P K Whelton.   

Abstract

Medicare's End-Stage Renal Disease (ESRD) Program makes renal replacement services accessible for the majority of Americans with renal failure. National data from Medicare demonstrate complex and variable patterns of use of renal replacement services among US racial and ethnic groups. The black population has consistently suffered from a greater than 3.5-fold higher rate of treated ESRD than has the white population. The rates of hypertensive, diabetic, and glomerulopathic ESRD are all substantially greater in blacks than in whites, and hypertension has accounted for a far greater proportion of ESRD in blacks than any other diagnosis. There is a paucity of national data on the occurrence of ESRD in Hispanic Americans. However, data from Texas strongly suggest that the incidence rate of treated ESRD is much higher in Mexican Americans than in non-Hispanic whites. Higher rates are apparent for each of the three most important causes of ESRD: hypertension, diabetes, and glomerulonephritis. Native Americans experience ESRD at a rate intermediate between those of whites and blacks, but their rate of diabetic ESRD is higher than in either blacks or whites. However, considerable diversity exists among Native American tribal groups. Significant barriers to the acquisition of preventive care have been identified, especially for blacks. While these barriers to preventive care are accompanied by a significantly impaired health status of the black American population, a specific causal relationship between impaired access to care for blacks and their predisposition to ESRD has not been established.

Entities:  

Mesh:

Year:  1992        PMID: 1585925     DOI: 10.1016/s0272-6386(12)80945-0

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

Review 1.  Racial and ethnic disparities in renal transplantation.

Authors:  Joanne M Churak
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

Review 2.  Hemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society.

Authors:  Keith C Norris; Sandra F Williams; Connie M Rhee; Susanne B Nicholas; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; L Ebony Boulware
Journal:  Semin Dial       Date:  2017-03-09       Impact factor: 3.455

3.  Association between circulating specific leukocyte types and incident chronic kidney disease: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Niu Tian; Alan D Penman; R Davis Manning; Michael F Flessner; Anthony R Mawson
Journal:  J Am Soc Hypertens       Date:  2011-11-03

4.  Amplification of Salt-Sensitive Hypertension and Kidney Damage by Immune Mechanisms.

Authors:  David L Mattson; John Henry Dasinger; Justine M Abais-Battad
Journal:  Am J Hypertens       Date:  2021-02-18       Impact factor: 2.689

5.  A study of renal outcomes in African American living kidney donors.

Authors:  Joseph M Nogueira; Matthew R Weir; Stephen Jacobs; Abdolreza Haririan; Denyse Breault; David Klassen; Deb Evans; Stephen T Bartlett; Matthew Cooper
Journal:  Transplantation       Date:  2009-12-27       Impact factor: 4.939

6.  Hypertensive cardiovascular disease in African Americans.

Authors:  R K Wali; M R Weir
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

Review 7.  The kidney as a target of hypertension.

Authors:  S Ljungman
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

8.  Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).

Authors:  Obidiugwu Kenrik Duru; Suying Li; Claudine Jurkovitz; George Bakris; Wendy Brown; Shu-Cheng Chen; Allan Collins; Michael Klag; Peter A McCullough; Janet McGill; Andrew Narva; Pablo Pergola; Ajay Singh; Keith Norris
Journal:  Am J Kidney Dis       Date:  2008-02       Impact factor: 8.860

Review 9.  Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease.

Authors:  Takeshi Usami; Genjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2006-03       Impact factor: 2.801

Review 10.  Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury.

Authors:  David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.